Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Video Observed Therapy Device Improves Probability of Tuberculosis Therapy Adherence; A Randomised Clinical Trial at a TB Reference Clinic in Lagos

View through CrossRef
Abstract Background Video Observed Therapy (VOT) is a method of adherence monitoring where participants transmit digital images of their treatment intake to a central location for review; either synchronously or asynchronously. VOT presents an option that can be explored for developing countries like Nigeria with a high TB burden, thereby reducing the TB burden and ultimately eliminating it. Methods The study was a two-arm individually randomised clinical trial conducted by Nigeria Institute of Medical Research (NIMR) in Lagos, Nigeria. Participants (100) were recruited to this study and randomised into either treatment (VOT) or DOT (Directly Observed Therapy) as control. Data were collected through the NimCure mobile app and participant records. We compared treatment outcomes between VOT and DOT and assessed average treatment effects by adjusting for gender, location (state), and age. Results A high rate of 100% adherence to TB treatment was achieved in VOT (97%) and DOT (79%). More females than males achieved 100% adherence to VOT, while more males achieved 100% adherence to DOT. Rural dwellers achieved 100% adherence to both VOT and DOT. There was a varied distribution across all age groups. The average adherence, if all participants were to use VOT, would be 0.1709 (z = 2.23, p = 0.026) more than the average that would be if the participants did not use VOT. Conclusion VOT through the NimCure application achieved the adherence objective and showed that VOT can be used for effective remote monitoring and management of Tuberculosis in Nigeria. NimCure can therefore be recommended for use in low-income settings.
Title: Video Observed Therapy Device Improves Probability of Tuberculosis Therapy Adherence; A Randomised Clinical Trial at a TB Reference Clinic in Lagos
Description:
Abstract Background Video Observed Therapy (VOT) is a method of adherence monitoring where participants transmit digital images of their treatment intake to a central location for review; either synchronously or asynchronously.
VOT presents an option that can be explored for developing countries like Nigeria with a high TB burden, thereby reducing the TB burden and ultimately eliminating it.
Methods The study was a two-arm individually randomised clinical trial conducted by Nigeria Institute of Medical Research (NIMR) in Lagos, Nigeria.
Participants (100) were recruited to this study and randomised into either treatment (VOT) or DOT (Directly Observed Therapy) as control.
Data were collected through the NimCure mobile app and participant records.
We compared treatment outcomes between VOT and DOT and assessed average treatment effects by adjusting for gender, location (state), and age.
Results A high rate of 100% adherence to TB treatment was achieved in VOT (97%) and DOT (79%).
More females than males achieved 100% adherence to VOT, while more males achieved 100% adherence to DOT.
Rural dwellers achieved 100% adherence to both VOT and DOT.
There was a varied distribution across all age groups.
The average adherence, if all participants were to use VOT, would be 0.
1709 (z = 2.
23, p = 0.
026) more than the average that would be if the participants did not use VOT.
Conclusion VOT through the NimCure application achieved the adherence objective and showed that VOT can be used for effective remote monitoring and management of Tuberculosis in Nigeria.
NimCure can therefore be recommended for use in low-income settings.

Related Results

Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Abstract Background :Tuberculosis (TB) is a major public health concern worldwide and is the 13th leading cause of death and the second deadliest infectious disease after C...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
PATHOMORPHOSIS OF EXTRAPULMONARY TUBERCULOSIS IN CHILDREN
PATHOMORPHOSIS OF EXTRAPULMONARY TUBERCULOSIS IN CHILDREN
Aim. To study clinical and epidemiological aspects of pathomorphosis of extrapulmonary tuberculosis clinical forms. Materials and Methods. Retrospective analysis of 138 case histo...

Back to Top